Machine learning and artificial intelligence (AI) are changing all industries. Pharma and MedTech are no exception to this.
The Internet of Things (IoT) has even arrived at the regulators: Apple, Samsung, Fitbit and other big names in Tech have been chosen for FDA’s new Software Precertification Pilot Program. Roche and J&J are now facing new neighbors as part of FDA’s Digital Health Innovation Action Plan.
Numerous experts even consider AI, big data and machine learning as our only way to contain constantly increasing healthcare costs.
As data becomes more important in all of Healthcare so does data driven benchmarking. The operational Excellence benchmarking data base of our partner ITEM (University of St.Gallen) is the world’s largest independent one and growing constantly.
As technologies advance, functional and hierarchical organizational structures become an obstacle to new opportunity if left unchanged. IoT and big data forces us to think in processes and once again process-oriented reorganization is still one of the best methods for adapting processes to changes in the environment.
Complexity is certain – success is optional.
With this in mind, we cordially invite you to follow us through this Pharma & HealthTech edition of our Complexity Management Journal.
In addition, consider joining the MedTech focus group of our Complexity Management Academy. And as always, we look forward to receiving your questions and comments.